Testing effectiveness (Phase 2)Study completedNCT00788892What this trial is testingTrial of CPX-351 in Newly Diagnosed Elderly AML PatientsWho this might be right forAcute Myeloid Leukemia Jazz Pharmaceuticals 126
Large-scale testing (Phase 3)UnknownNCT04083911What this trial is testingStudy of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60Who this might be right forAcute Myeloid LeukemiaInduction Chemotherapy The First Affiliated Hospital of Soochow University 50
Early research (Phase 1)Looking for participantsNCT06634394What this trial is testingAPVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AMLWho this might be right forAcute Myeloid Leukemia (AML) Aptevo Therapeutics 39
Testing effectiveness (Phase 2)Ended earlyNCT02341495What this trial is testingDeferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed AML Patients Over 65Who this might be right forAcute Myeloid Leukemia Elizabeth Henry 4
Testing effectiveness (Phase 2)Ended earlyNCT04326439What this trial is testingAflacLL1901 (CHOA-AML)Who this might be right forAcute Myeloid LeukemiaAML, Childhood Emory University 8
Early research (Phase 1)Study completedNCT04277442What this trial is testingTesting Nivolumab in Combination With Decitabine and Venetoclax in Patients With Newly Diagnosed TP53 Gene Mutated Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia National Cancer Institute (NCI) 1
Early research (Phase 1)Active Not RecruitingNCT04953780What this trial is testingPhase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Diagnosed AMLWho this might be right forAcute Myeloid Leukemia West Virginia University 6
Not applicableStudy completedNCT04774744What this trial is testingEffect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic LeukemiaWho this might be right forAcute Myeloid LeukemiaChronic Lymphocytic Leukemia M.D. Anderson Cancer Center 157
Not applicableNo Longer AvailableNCT03114228What this trial is testingAn Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML)Who this might be right forFLT3-mutated Acute Myeloid Leukemia Novartis Pharmaceuticals
Large-scale testing (Phase 3)Looking for participantsNCT06345365What this trial is testingMA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukaemia Zhongnan Hospital 154
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07664839What this trial is testingStudy on the Efficacy and Safety of VA Regimen Compared to "3+7" Regimen in Newly Diagnosed AML With NPM1 or IDH1/IDH2 MutationsWho this might be right forAcute Myeloid LeukemiaNPM1 MutationIDH1 Mutation+1 more Shen yang 148
Testing effectiveness (Phase 2)Active Not RecruitingNCT05520567What this trial is testingGilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia (AML)FLT3-mutated Acute Myeloid Leukemia Astellas Pharma Global Development, Inc. 70
Testing effectiveness (Phase 2)Study completedNCT03030612What this trial is testingARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)Who this might be right forLeukemia, Myeloid, AcuteMyelodysplastic Syndromes OncoVerity, Inc. 38
Early research (Phase 1)Ended earlyNCT00156299What this trial is testingGene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium TrisalicylateWho this might be right forLeukemia Rutgers, The State University of New Jersey 15
Testing effectiveness (Phase 2)Study completedNCT02238925What this trial is testingAn Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS PatientsWho this might be right forAcute Myeloid Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)Myelodysplastic Syndrome (MDS) Jazz Pharmaceuticals 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04023526What this trial is testingCusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive ChemotherapyWho this might be right forLeukemia, Myeloid, Acute OncoVerity, Inc. 103
Testing effectiveness (Phase 2)Study completedNCT01238211What this trial is testingCombination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11+5 more National Cancer Institute (NCI) 61
Not applicableUnknownNCT04168138What this trial is testingD-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly PatientsWho this might be right forAcute Myeloid Leukemia Huihan Wang 20
Testing effectiveness (Phase 2)Study completedNCT01567059What this trial is testingTosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeWho this might be right forAcute Myeloid Leukemia With Multilineage DysplasiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+6 more Fred Hutchinson Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT04230239What this trial is testingClinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid LeukemiaWho this might be right forNewly Diagnosed Secondary or High Risk AML PETHEMA Foundation 59